Plain-English translation of NCT07073287 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing cerebello-spinal direct current stimulation (csDCS)—a non-invasive technique that uses mild electrical stimulation to activate specific parts of the brain and spinal cord—to see if it can help people who have had a stroke regain better walking ability and mobility. The treatment will be combined with treadmill training over two weeks. Researchers want to understand whether this treatment actually works and whether it is safe.
Many people who survive a stroke struggle with walking and movement problems that can last for months or years. This trial exists to test whether this new brain and spinal cord stimulation technique, paired with exercise, could help restore walking ability in ways that current treatments cannot.
You likely qualify if…
You likely don't qualify if…
You will come in daily for two weeks. During each session, you will either receive the active brain and spinal cord stimulation or a sham (placebo) version—neither you nor the researchers will know which one you're getting at first. Either way, you will then walk on a treadmill for training. The stimulation itself is painless and non-invasive, delivered through electrodes placed on your skin.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Brazil